Ann: PAT-DX1 Crosses Blood Brain Barrier to Reduce Tumour Size, page-85

  1. 19,944 Posts.
    lightbulb Created with Sketch. 7308
    Yes I am an expert in this area. I don't invest in ASX listed biotechs because of this, but I do keep an eye on them.

    I actually made money on MUS (not as much as I would have if I had sold out at the top) because I bought in very early and sold most of my position in the 4c range after the crash. I still retain a modest position as penance.

    RAN is an interesting investment. I am not down too much on it (my average is a little under 6c), but I am invested in RAN because of the environmental aspect. I want to see RAN succeed so we stop chopping down rainforests to make pallets. It is high risk, but at the current SP I am willing to do what I can to help them succeed. It might even turn out to be a good investment, but the odds are against it.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.1¢
Change
-0.001(50.0%)
Mkt cap ! $2.365M
Open High Low Value Volume
0.1¢ 0.2¢ 0.1¢ $7.467K 4.095M

Buyers (Bids)

No. Vol. Price($)
46 115294083 0.1¢
 

Sellers (Offers)

Price($) Vol. No.
0.2¢ 52771391 23
View Market Depth
Last trade - 16.10pm 18/07/2025 (20 minute delay) ?
PAB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.